Patents on streptogramin antibiotics

Bibliography

• COCITO C: Antibiotics of the virginiamycin family, inhibitions which contain synergistic component. Microb. Rev (1979) 43(2):145–198.
   PubMedGoogle Scholar
• ••Chemistry of streptogramins andstructure-activity relationships.
   Google Scholar
• TAVARES F, LAWSON JP, MEYERS AL: Total synthesis of streptogramin antibiotics. 0-Madumycin II. 1. Am. Chem. Soc. (1996) 118:3303–3304.
   Google Scholar
• DVORAK CA, SCHMITZ WD, POON JDet al.: The synthesis of streptogramin antibiotics: griseoviridin and its C-8 epimer. Angew. Chem. Int. Ed. (2000), 39: 1664–1666.
   Google Scholar
• AUMERCIER M, LE GOFFIC F: Mechanisms of action of the macrolide and streptogramin antibiotics. In: Macrolides chemistry pharmacology and clinical use. Bryskier AJ, Butzler JP, Neu HC (Eds), Arnette Blackwell, Paris, France (1993):115–123.
   Google Scholar
• BREUILLES P, UGUEN D: Total synthesis of pristinamycin IIB. Tetrahedron Lett. (1998) 39:3149–3152.
   Web of Science ®Google Scholar
• PARIS JM, BARRIERE JC, SMITH C, BOST PE: The chemistry of pristinamycin. In: Recent progress in the chemical synthesis of antibiotics. Luckacs G, Ohno M (Eds), Springer, Berlin-Heidelberg, Germany (1990):183–248.
   Google Scholar
• •Chemistry of pristinamycin and structure-activity relationships.
   Google Scholar
• BARRIERE JC, BERTHAUD N, BEYER D, DUTKA-MALEN S, PARIS JM, DESNOTTES JF: Recent developments in streptogramin research. Curr. Pharm. Der. (1998) 2:155–180.
   Google Scholar
• ••Review on the chemistry and the in vitroand in vivo activity of new compounds.
   Google Scholar
• AUMERCIER M, BOUHALLAB S, CAPMAU M-L, LE GOFFIC F: RP-59000: a proposed mechanism for its bactericidal activity. Antimicrob. Chemother. (1992) 30(Suppl.A):9–14.
   Google Scholar
• DI GIAMBATTISTA M, CHINALI G, COCITO C: The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes. J. Antimicrob. Chemother. (1989) 24:485-507. Mechanisms of action of streptogramins.
   Google Scholar
• COCITO C, DI GIAMBATTISTA M, NYSSEN E, VANUFFEL P: Inhibition of protein syhthesis by streptogramins and related antibiotics. Antimicrob. Chemothei: (1997) 39(Suppl.A):7–13.
   Google Scholar
• ••Mechanisms of action of streptogramins.
   Google Scholar
• DI GIAMBATTISTA M, VANNUFFEL P, SUNAZUKA T, JACOB T, -OMURA S, COCITO C: Antagonistic interactions of macrolide and synergymycins on bacterial ribosomes. J. Antimicrob. Chemother. (1986) 18:307–315.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• COCITO C, CHINALI G: Molecular mechanism of virginiamycin-like antibiotics on bacterial cell free systems for protein synthesis.' Antimicrob. Chemother (1985) 16(SuppLA):35–52.
   Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• COCITO C, VOORMA H, BOSCH L: Interference of virginiamycin M with the initiation and the elongation of peptide chains in cell-free systems. Biochim. Biophys. Acta (1974) 340:285–298.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• COCITO C, KAJI A: Virginiamycin M - a specific inhibitor of the acceptor site of ribosomes. Biochimie (1971) 53:763–770.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• CHINALI G, MOREAU P, COCITO C: The action of virginiamycin M on the acceptor, donor and catalytic sites of peptidyltransferase. J. Biol. Chem. (1984)
   Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• ENNIS H, DUFFY K: Vernamycin A inhibits the non enzymatic binding of fMet-tRNA to ribosomes. Biochim. Biophys. Acta (1972) 281:93–102.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• NYSSEN E, DI GIAMBATTISTA M, COCITO C: Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochint. Biophys. Acta (1989) 1009:39–46.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• CHINALI G, DI GIAMBATTISTA M, COCITO C: Ribosome protection by tRNA derivatives against inactivation by virginiamycin M. Evidences for 2 types of interaction of tRNA with the donor site of the peptydiltransferase. Biochem. (1987) 26:1592–1597.
   Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• DI GIAMBATTISTA M, IDE G, ENGELBORGHS Y, COCITO C: Analysis of fluorescence quenching of ribosome-bound virginiamycin S. j. Biol. Chem. 259:6334-6339.
   Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• MOREAU P, ENGELBORGHS Y, DI GIAMBATTISTA M, COCITO C: Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes. Biol Chem. (1983) 258:14233–14338.
   Google Scholar
• •Mechanisms of action of streptogramins.
   Google Scholar
• MOREAU P, DI GIAMBATTISTA M, COCITO C: The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins. Biochim. Biophys. Acta (1983) 739:164–172.
   PubMed Web of Science ®Google Scholar
• LECLERCQ R, COURVALIN P: Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother: (1991) 35:1267–1272.
   PubMed Web of Science ®Google Scholar
• LECLERCQ R, COURVALIN P: Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. (1991) 35:1273–1276.
   PubMed Web of Science ®Google Scholar
• WEISBLUM B: Macrolide resistance. Drug Res. Up. (1998) 1:29–41.
   PubMed Web of Science ®Google Scholar
• WEISBLUM B: Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemothei: (1995) 39:577–585.
   PubMed Web of Science ®Google Scholar
• ••Mechanisms of action and resistance oferythromycin and related compounds.
   Google Scholar
• WEISBLUM B: Insights into erythromycin action from studies of its activity as an inducer of resistance. Antimicrob. Agents Chemother. (1995) 39:797–805.
   PubMed Web of Science ®Google Scholar
• ••Mechanisms of action and resistance oferythromycin and related compounds.
   Google Scholar
• VANNUFFEL P, DI GIAMBATTISTA M, COCITO C: The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. Biol. Chem (1992) 267:16114–16120.
   Google Scholar
• ••Mechanisms of action and resistance ofMLS antibiotics.
   Google Scholar
• VANNUFFEL P, DI GIAMBATTISTA M, MORGAN EA, COCITO C: Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J. Biol. Chem. (1992) 267:8377–8382.
   PubMed Web of Science ®Google Scholar
• DOUTHWAITE S, PRINCE JB, NOLLER HF: Evidence for functional interaction between domain II and V of 23S ribosomal RNA from an erythromycin resistant mutant. Proc. Natl. Acad. Sci. USA(1985) 82:8330-8334. Mechanisms of action and resistance of MLS antibiotics.
   Google Scholar
• DOUTHWAITE S: Functional interactionswithin 23S rRNA involving the peptidyltransferase center. Bacterioi (1992) 174:1333–1338.
   PubMed Web of Science ®Google Scholar
• MOAZED D, NOLLER HF: Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. BiocImme (1987) 69:879–844.
   Google Scholar
• ••Mechanisms of resistance of MLSantibiotics.
   Google Scholar
• BARTA A, STEINER G, BROSIUS J, NOLLER HF, KUECHLER E: Identification of a site on 23S ribosomal RNA located at the peptidyl transferase center. Proc. Natl. Acad. Sci. USA (1984) 81:3607–3611.
   PubMed Web of Science ®Google Scholar
• ••Mechanisms of resistance of MLSantibiotics.
   Google Scholar
• LAI CJ, WEISBLUM B: Altered methylation of ribosomal RNA in an erythromycin resistant strain of Staphylococcus aureus. Proc. Natl. Acad. Sci. USA (1971) 68:856–860.
   PubMed Web of Science ®Google Scholar
• ••Mechanisms of resistance of MLSantibiotics.
   Google Scholar
• SKINNER R, CUNDLIFFE E, SCHMIDT FJ: Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J. Biol. Chem. (1983) 258:12702–12706.
   PubMed Web of Science ®Google Scholar
• GRYCZAN T, GRANDI G, HAHN J, GRANDI R, DUBNAU D: Conformational alteration of mRNA structure and the posttrascriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res. (1980) 8:6081–6097.
   PubMed Web of Science ®Google Scholar
• HORINOUCHI S, WEISBLUM B: Post-transcritpional modification of mRNA conformation: mechanism that regulates erythromycin induced resistance. Proc. Nati Acad. Sci. USA (1980) 77:7079–7083.
   PubMed Web of Science ®Google Scholar
• KWAK JH, CHOI EC, WEISBLUM B: Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis. Bacteria. (1991) 173:4725–4735.
   PubMed Web of Science ®Google Scholar
• ••Mechanisms of resistance of MLSantibiotics.
   Google Scholar
• CUNDLIFFE E. Recognition sites for antibiotics within rRNA. In: The ribosome: structure, functions, and evolution. Hill WE, Dahlberg A, Garrett RA, Moore PB, Schlessinger D, Warner JR (Eds), American Society for Microbiology, Washington DC, USA (1990):479–490.
   Google Scholar
• DOUTHWAITE S, AAGAARD C: Erythromycin binding is reduced in ribosomes with conformational alteration in the 23S rRNA peptidyl transferase loop. J. Ma Biol (1993) 232:725–731.
   Google Scholar
• KLOSS P, XIONG L, SHINABARGER DL,MANKIN AS: Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. Ma Biol. (1999) 294:93–103.
   Google Scholar
• MANKIN AS, GARRET RA: Chloramphenicol resistance mutations in the single 23S rRNA gene of the archaeon Halobacterium halobium. Bacteria. (1991) 173:3559–3563.
   PubMed Web of Science ®Google Scholar
• DEPARDIEU F, COURVALIN P: Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. (2001) 45:319–323.
   PubMedGoogle Scholar
• RODRIGUEZ-FONSECA C, AMILS R, GARRETT RA: Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. J. Ma. Biol. (1995) 247:224–235.
   Google Scholar
• VANNUFFEL P, DI GIAMBATTISTA M, COCITO C: Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. Nucleic Acids Res. (1994) 22:4449–4453.
   PubMed Web of Science ®Google Scholar
• ALLIGNET J, LONCLE V, SIMENEL C,DELPIERRE M, EL SOHL N: Sequence of a staphylococcal gene vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics. Gene (1993) 130:91–98.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• ALLIGNET J, EL SOHL N: Diversity among the Gram-positive acetyltransferase inactivating streptogramin A and structurally realted compounds and characterization of a new staphylococcal determinat vatg. Antimicrob. Agents Chemother. (1995) 39:2027–2036.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• ALLIGNET J, AUBERT S, MORVAN A, EL SOHL N: Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics. Antimicrob. Agents Chemother. (1996) 40:2523-2528. Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• HOU CT, PERLMAN D, SCHALLOCK MR: Microbial transformation of peptide antibiotics. VI. Purification and properties of a peptide lactonase hydrolyzing dihydrostaphylomycin S. J. Antibiotics (1970) 23:35–42.
   Google Scholar
• •Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• KIM CH, OTAKE N, YONEHARA Y: Studies on mikamycin B lactonase. Part I. Degradation of mikamycin B by Streptomyces mitakensis. Antib. (1974) 27:903–908.
   Google Scholar
• •Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• ALLIGNET J, LONCLE V, MAZODIER P, EL SOHL N: Nucleotide sequence of a staphylococcal plasmid gene vgb, econding a hydrolase incativating the B components of virginiamycin-like antibiotic. Plasmid (1988) 20:271–275.
   PubMed Web of Science ®Google Scholar
• •Mechanisms of resistance of MLS antibiotics.
   Google Scholar
• MUKHATAR TA, KOTEVA KP, HUGHES DH, WRIGHT GD: Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis. Biochemistry (2001) 40:8877–8886.
   PubMedGoogle Scholar
• SUGANTINO M, RODERICK SL: Crystal structure of Vat(D): an acetyltransferase that inactivates streptogramin group A antibiotics. Biochemistry (2002) 41:2209–2216.
   PubMedGoogle Scholar
• BOZDOGAR B, LECLERCQ R: Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob. Agents Chemother. (1999) 43:2720–2725.
   PubMedGoogle Scholar
• BATEMAN KP, YANG K, THIBAULT P, WHITE RL, VINING LC: Inactivation of etamycin by a novel elimination mechanism in Streptomyces lividans. j Am. Chem. Soc. (1996) 118:5335–5338.
   Google Scholar
• ALLIGNETJ, LONCLE V, EL SOHL N: Sequence of a staphylococcal plasmid gene wa, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics. Gene (1992) 117:45–51.
   PubMedGoogle Scholar
• ••Sequence of a gene involved instreptogramin resistance.
   Google Scholar
• ALLIGNET J, EL SOHL N: Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds.658Gene (1997) 202:133–138.
   Google Scholar
• ••Characterisation of a gene involved instreptogramin resistance.
   Google Scholar
• HAROCHE J, ALLIGNET J, BUCHRIESER C, EL SOLH N: Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds. Antimicrob. Agents Chemother. (2000) 44:2271–2275.
   PubMed Web of Science ®Google Scholar
• ••Characterisation of a gene involved instreptogramin resistance.
   Google Scholar
• BRENNAN CJ, CAMPAGNE JM: Synthetic studies towards the group A streptogramin antibiotics. Synthesis of the C-9 — C-23 fragment. Tetrahedron Lett. (2001) 42:5195–5197.
   Web of Science ®Google Scholar
• PUTNAM SD, JONES RN, JOHNSON DM et al.: In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/ RPR 106950): a novel orally administered streptogramin combination. Diagn. Microbiol Infect. Dis. (1997) 28:139–147.
   PubMed Web of Science ®Google Scholar
• SPANGLER S, JACOBS M, APPELBAUM P: Antipneumococcal activity of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin) and 8 oral I3-lactams. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco (1995) Abstract F113.
   Google Scholar
• BARRY AL, FUCHS PC, BROWN SD: In vitro activity of an orally administered streptogramin (RPR 106972) compared to quinupristin/dalfopristin and erythromycin. Eur. Clin. Microbiol Infect. Di s (1997) 16:155–158.
   PubMed Web of Science ®Google Scholar